Skip Navigation LinksHome > November 2011 - Volume 111 - Issue 11 > Drug Label Revisions for Two Psychiatric Drugs
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000407286.02007.96
Drug Watch

Drug Label Revisions for Two Psychiatric Drugs

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* The daily dosage of the anti-depressant citalopram (Celexa) has now been limited to 40 mg because of potential dose-dependent QT prolongation and the risk of life-threatening arrhythmias.

* The label for the atypical antipsychotic asenapine (Saphris) has been revised to warn of possibly serious allergic reactions, including anaphylaxis and angioedema.

© 2011 Lippincott Williams & Wilkins, Inc.

Login